TABLE 1.

Telemedicine Regulatory Requirements^7,8

Pre-COVID-19	During COVID-19
Originating site: Reimbursable sites of care included provider offices, hospitals, health clinics, pharmacies, skilled nursing facilities, ambulances	“Originating site” requirement was waived so that patients can receive services from their homes
Device type: Personal phones and tablets were unauthorized to be used; only certain HIPAA-compliant modalities were acceptable for use	Patients are now able to use personal phones and tablets to receive services; everyday communication technologies like FaceTime and Skype are acceptable
Patient and service eligibility: Limited range of services were provided via telemedicine; patients were required to have seen the provider within previous 3 yr to access remote services	Wide range of services are now available; new patients are now eligible to receive telemedicine services
Prescribing guidance: Prescription for a controlled substance required in-person medical evaluation	Clinicians are now able to prescribe schedule II to V controlled substances to patients seen using telemedicine communication